Summary
To evaluate the reactogenicity and immunogenicity of aHaemophilus influenzae type b conjugate vaccine (HbOC) and of a tricomponent acellular pertussis vaccine (DTaP) when injected simultaneously into either contralateral arms or into contralateral thighs, 110 infants were enrolled to receive three doses of DTaP at 3, 4, and 5 months and two HbOC doses at 3 and 5 months of age. Administration of either of the two vaccines into arms was associated with significantly more local side effects than administration into thighs. There was no difference in geometric mean concentration (GMC) values for any of the four vaccine antigens between subjects who had been vaccinated into arms or thighs. After immunization, all children had protective antibody titers to diphtheria toxin. While post vaccination the mean anti-tetanus toxoid GMC was ≥ 1.25 IU/ml, there was no significant rise as compared to the GMC before vaccination. GMCs of antibodies against the various pertussis antigens were similar to those observed before with the same DTaP vaccine. The simultaneous administration of DTaP and HbOC was safe and immunogenic irrespective of the site of vaccine administration, but significantly more local reactions occurred when vaccines were injected into arms.
Similar content being viewed by others
References
Centers for Disease Control Progress toward elimination ofHaemophilus influenzae type b disease among infants and children. MMWR 44 (1995) 545–550.
Klug, B., Plesker, R., Bittner-Grünwald, P., Czapla, D., Eckert-Ziem, M., Schwanig, M., Hoffmann, A. Haemophilus influenzae Typ-b-Konjugatimpfstoffe. Monatsschr. Kinderheilkd. 142 (1994) 350–354.
von Kries, R., Windfuhr, A., Lucking, A., Helwig, H. PreventingHaemophilus influenzae type b meningitis after routine childhood immunization with conjugate vaccines. Lancet 340 (1992) 592–594.
Peltola, H., Kilpi, T., Anttila, M. Rapid disappearance ofHaemophilus influenzae type b meningitis after routine childhood immunization with conjugate vaccines. Lancet 344 (1994) 469.
Black, S. B., Shinefield, H. R., Fireman, B., Jiatt, R., Polen, M., Vittinghoff, E., andthe Northern California Kaiser Permanente Vaccine Study Center Pediatrics Group Efficacy in infancy of oligosaccharide conjugateHaemophilus influenzae type b (HbOC) vaccine in a United States population of 61,080 children. Pediatr. Infect. Dis. J. 10 (1991) 97–104.
NN Impfverhalten. Infektionsepidemiologische Forschung 4 (1995) 22.
Schmitt, H. J., Wirsing von König, C. H., Neiss, A., Bogaerts, H., Bock, H. L., Schulte-Wissermann, H., Gahr, M., Schult, R., Folkens, J.U., Rauh, W., Clemens, R. Efficacy of acellular pertussis vaccine in early childhood after household exposure. JAMA 275 (1996) 37–41.
Trollfors, B., Taranger, J., Lagergard, T., Lind, L., Sundh, V., Zackrisson, G., Lowe, C. U., Blackwelder, W. A placebo-controlled trial of a pertussis-toxoid vaccine. N. Engl. J. Med. 333 (1995) 1045–1050.
Greco, D., Salmaso, S., Mastrantonio, P., Giuliano, M., Tozzi, A. E., Anemona, A., Ciofi Degli Atti, M. L., Giammanco, A., Panei, P., Blackwelder, W. C., Kelin, D. L., Wassilak, S., andthe Progetto Pertosse Working Group A controlled trial of two acellular vaccines and one whole cell vaccine against pertussis. N. Engl. J. Med. 334 (1996) 341–348.
Gustafsson, L., Hallander, H. O., Olin, P., Reizenstein, E., Storsaeter, J. A controlled trial of a two-component acellular, a five-component acellular and a whole cell pertussis vaccine. N. Engl. J. Med. 334 (1996) 349–355.
Deutsche Gesellschaft für Pädiatrische Infektiologie Schutzimpfungen. In: DGPI-Handbuch 1995, Futuramed Verlag, München 1995.
Barra, A., Schulz, D., Ancoutier, P., Preud'homme, J. R. Measurement of anti-Haemophilus influenzae type b capsular polysaccharide antibodies by ELISA. J. Immunol. Meth. 115 (1988) 111–117.
Camargo, M. E., Silveira, L., Furuta, J. A., Oliveira, E. P. T., Germak, O. A. Immunoenzymatic assay of anti-diphtheric toxin antibodies in human serum. J. Clin. Microbiol. 20 (1984) 772–774.
Melville-Smith, M., Seagroatt, V., Watkins, J. A comparison of enzyme-linked immunosorbent assay (ELISA) with the toxin neutralisation test in mice as a method for the estimation of tetanus antitoxin in human sera. J. Biol. Stand. 11 (1983) 137–144.
Schmitt, H. J., Schuind, A., Knuf, M., Beutel, K., Schulte-Wissermann, H., Gahr, M., Schult, R., Folkens, J., Rauh, W., Bogaerts, H., Bock, H. L., Clemens, R. Clinical experience of a tricomponent acellular pertussis vaccine combined with diphtheria and tetanus toxoids for primary vaccination in 22,505 infants. J. Pediatr. 129 (1996) 695–701.
Schmitt, H. J., Beutel, K., Schuind, A., Knuf, M., Wagner, S., Müschenborn, S., Bogaerts, H., Bock, H. L., Clemens, R. Reactogenicity and immunogenicity of a booster dose of a combined diphtheria, tetanus and tricomponent acellular pertussis vaccine at 14–28 months of age. J. Pediatr. 130 (1997) 616–623.
Decker, M. D., Edwards, K. M., Steinhoff, M. C., Rennels, M. B., Pichichero, M. E., Englund, J. A., Anderson, E. L., Deloria, M. A., Reed, G. F. Comparison of 13 acellular pertussis vaccines: adverse reactions. Pediatrics 96 (1995) 557–566.
Rennels, M. B., Reed, G. F., Decker, M. D., Edwards, K. M., Pichichero, M. E., Deloria, M. A., Englund, J. A., Anderson, E. L., Steinhoff, M. C., Deforest, A., Meade, B. D. Simultaneous administration ofHaemophilus influenzae type b vaccine with acellular or whole cell pertussis vaccine: effects on reactogenicity and immune response to pertussis vaccines. Pediatrics 96 (1995) 576–579.
Schmitt, H. J., Müschenborn, S., Wagner, S., Knuf, M., Bock, H. L., Bogaerts, H., Clemens, C. Immunogenicity and reactogenicity of a bicomponent and a tricomponent acellular pertussis-diphtheria-tetanus (DTaP) vaccine in primary immunization and as second year booster: a double-blind, randomized trial. Internat. J. Infect. Dis. 1 (1996) 1–8.
Eskola, J., Ölander, R. M., Hovi, T., Litmanen, L., Peltola, S., Kaythy, H. Randomised trial of the effect of co-administration with acellular pertussis DTP vaccine on immunogenicity ofHaemophilus influenzae type b conjugate vaccine. Lancet 348 (1996) 1688–1692.
ACIP Recommendations for use ofHaemophilus b conjugate vaccines and a combined diphtheria, tetanus, pertussis, andHaemophilus b vaccine. MMWR Recommendations and Reports 42 (1993) 1–12.
Edwards, K. M., Meade, B. D., Decker, M. D., Reed, G. F., Rennels, M. B., Steinhoff, M. C., Anderson, E. L., Englund, J. A., Pichichero, M. E., Deloria, M. A., Deforest, A. D. Comparison of 13 acellular pertussis vaccines: overview and serologic response. Pediatrics 96 (1995) 548–557.
Storsaeter, J., Blackwelder, W. C., Hallander, H. O. Pertussis antibodies, protection, and vaccine efficacy after household exposure. Am. J. Dis. Child 146 (1992) 167–172.
Centers for Disease Control, Anonymous: Suboptimal response to hepatitis B vaccine given by injection into the buttock. MMWR 34 (1985) 105–108.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Schmitt, H.J., Wirsing von König, C.H., Zepp, F. et al. Immunogenicity and reactogenicity of HbOC vaccine administered simultaneously with acellular pertussis vaccine (DTaP) into either arms or thighs of infants. Infection 25, 298–302 (1997). https://doi.org/10.1007/BF01720400
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01720400